Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model
Journal of Food and Drug Analysis, ISSN: 1021-9498, Vol: 28, Issue: 1, Page: 103-114
2020
- 24Citations
- 101Usage
- 47Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations24
- Citation Indexes24
- 24
- CrossRef15
- Usage101
- Abstract Views66
- Downloads35
- Captures47
- Readers47
- 46
Article Description
In the present study, we investigated the effects of Probiotic mix 1 (Pm1) with Lactobacillus plantarum subsp. plantarum, Lactobacillus paracasei subsp. paracasei, and Streptococcus salivarius subsp. thermophilus on preventing renal injury using a chronic kidney disease (CKD) minipig model previously developed in our lab using cisplatin-induced CKD in Lanyu pigs. The results indicated that the high dosage Pm1 (H.Pm1) group demonstrated lower incidence of lesions, including atrophy, mononuclear inflammation, cell infiltration, and interstitial fibrosis in renal tubules in hematoxylin and eosin (H&E) and Masson’s trichrome stain. We further systematically investigated the preventing effect of Pm1. The H.Pm1 group decreased inflammatory cytokines production and increased the level of superoxide dismutase activity in plasma. The pigs fed with high dosage of Pm1 group also showed reduced both creatinine and blood urea nitrogen (BUN) when compared with the cisplatin group. Microbiota results indicated that Pm1-intervention not only reduced the abundance of Gram-negative bacteria but also affected the abundance of specific genera biomarkers, Anaerovibrio, possible_genus _SK018, Holdemanella, and Lachnospiraceae _UCG_010 in gut microbiota, leading to decreased inflammation and apoptosis in the kidney and further prevention/alleviation of the symptoms of CKD.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1021949819300961; http://dx.doi.org/10.1016/j.jfda.2019.10.001; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85074385500&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/31883598; https://www.jfda-online.com/journal/vol28/iss1/8; http://dx.doi.org/10.38212/2224-6614.1225; https://linkinghub.elsevier.com/retrieve/pii/S1021949819300961; https://www.jfda-online.com/cgi/viewcontent.cgi?article=1225&context=journal; https://dx.doi.org/10.38212/2224-6614.1225; https://www.jfda-online.com/journal/vol28/iss1/8/; https://dx.doi.org/10.1016/j.jfda.2019.10.001
The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know